Myoepitheliomas are rare benign neoplasms of salivary glands representing less than 1% of all salivary gland tumors. This tumor is usually located in the parotid gland and less frequently in the submandibular gland and minor salivary glands that are distributed throughout the oral cavity. Diagnosis of tumor is based on evaluation of histological feature, although immunohistochemical analysis confirms the myoepithelial origin of tumor cells and the final diagnosis. Herein, a case of plasmacytoid myoepithelioma of soft palate in an adult male is presented along with review of the literature.
INTRODUCTION
Myoepitheliomas are rare tumors of salivary glands constituting less than 1% of all salivary gland tumors. 1 It was first described by Sheldon 2 in 1943, and was then considered to be a variant of pleomorphic adenoma. The most common site of myoepithelioma is parotid gland and less common locations include the submandibular gland or minor salivary glands that are distributed throughout the oral cavity. Myoepitheliomas of the soft or hard palate account for 21% of all cases and for 93% of intraoral cases. 3 Myoepithelioma is composed of myoepi- 
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or electron microscopy and immunohistochemistry is essential to establish the diagnosis of this rare entity. 4, 5 We report here a case of plasmacytoid myoepithelioma of soft palate.
CASE REPORT
A 35-year-old male presented to us with a year-old mass of soft palate, insidious in onset, progressively increasing in size, associated with change in voice, and snoring and mouth breathing during night. Mass was not associated with pain or any discharge. There was no difficulty in deglutition. Clinically, the mass was solid, firm in consistency, well-circumscribed about 4 × 3 cm in size (Fig. 1) . The overlying mucosa was normal and uvula was distorted. The hard palate was normal on clinical examination. No regional lymphadenopathy and other systemic problems were reported. Physical examination was normal with no sign of metastases. Radiological investigation revealed no bony abnormality (Fig. 2) . Fine-needle aspiration cytology (FNAC) of the mass revealed plasmacytoid cells.
Wide surgical excision of lesion was carried out under general anesthesia. Soft palate was repaired by end-to-end suturing of mucosa. Grossly, the lesion was a well-circumscribed, gray white, solid encapsulated mass of dimension 4 × 3.5 × 1.5 cm (Fig. 3) . Histologically, the tumor comprised sheets and nests of plasmacytoid myoepithelial cells with mucinous and cartilaginous differentiation. No dysplastic or malignant changes were (Fig. 4) . The final histopathological examination report confirmed the diagnosis of benign plasmacytoid myoepithelioma. The patient is followed up since 2 months, with no reports of recurrence till date.
To confirm the myoepithelial nature of neoplastic cells, the immunohistochemical reaction for cytokeratin, S100, and vimentin were performed. Immunohistochemical reaction revealed positivity against all the antibodies.
DISCUSSION
Myoepitheliomas are benign neoplasms of salivary glands derived from myoepithelial cells. These tumors represent less than 1% of all salivary gland tumors. Although the architectural variations of myoepithelioma are well-defined, it must be emphasized that they can at times be difficult to differentiate from other tumors, particularly pleomorphic adenoma. Myoepithelioma and pleomorphic adenoma have been suggested to be two different forms of the same entity. 8 It has been proposed that if the neoplasm contains less than 5% of ductal and acinar component, it must be named myoepithelioma. 7 It is very important to differentiate myoepithelioma from malignant neoplasms. 9 Malignant tumors are differentiated from their benign counterparts by their characteristic multilobulated architecture, presence of infiltrating growth, necrotic area, polymorphism, and mitotic figures. 10 Since none of these features of malignancy was observed on histopathological examination in this case, it was considered as typical benign neoplasm. Diagnosis of tumor is based on evaluation of histological feature, although immunohistochemical analysis confirms the myoepithelial origin of tumor cells and the final diagnosis. 11 Immunohistochemically, various markers have been proposed for myoepithelioma, which includes muscle-specific antigen (MSA), a marker of myogenous differentiation, and epithelial filaments of cytokeratin. S-100 protein immunoreactivity has also been used as an evidence of myoepithelial differentiation. S-100 protein is usually positive in the neoplastic myoepithelial cells but not the normal salivary gland myoepithelial cells. Vimentin (an intermediate filament protein of fibroblast and other mesenchymal cells) is one of the earliest indicators of neoplastic myoepithelial cell differentiation. 5 Recently, glial fibrillary acidic protein (GFAP) is also found to be potentially expressive in myoepithelioma. Both Vimentin and GFAP are more commonly used as markers for myoepithelioma than MSA. 4, 5 In the case presented herein, the tumor reveals histologic features of benign plasmacytoid myoepithelioma and immunohistochemical analysis showed cytokeratin, S100 protein, and Vimentin positivity. The salivary gland tumors comprise pleomorphic adenoma, adenoid-cystic carcinoma, and epithelial-myoepithelial carcinoma. 13 Although these lesions hold the myoepithelial cells as their main neoplastic cells, their clinical management may vary consistently. As adenoid-cystic carcinoma, epithelial-myoepithelial carcinoma and mucoepidermoid carcinoma demand surgical excision with postoperative intensity-modulated radiotherapy with or without chemotherapy.
On the contrary, simple surgical excision is the most accepted treatment of myoepitheliomas and other benign salivary gland tumors. Recurrence rate is very low in these tumors.
CONCLUSION
Plasmacytoid myoepitheliomas are rare salivary gland neoplasms. These should be ditinguished carefully from other tumors arising from salivary glands, such as pleomorphic adenoma and adenoid-cystic carcinoma. Along with histologic features, diagnosis should be confirmed by immunohistochemical analysis. The treatment of choice for myoepithelioma is complete surgical excision with margin of nonlesional area with very low risk of recurrence after surgery. In cases where surgical operation is not possible, radiation therapy should be considered.
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